Market Outlook

By 2035, the U.S. Cloud-Connected Medical Devices Market is expected to reach approximately USD 220.30 billion, expanding at an aggressive CAGR of 16.91% during the forecast period 2026–2035. The market was valued at approximately USD 46.20 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

For the purposes of this report, cloud-connected medical devices include FDA-regulated or clinically deployed medical devices capable of securely transmitting physiological measurements, diagnostic information, device status, treatment data, alarms, or operating parameters through internet-connected infrastructure to remote clinical applications, enterprise platforms, device-management systems, or manufacturer-operated cloud environments. The scope includes connected patient monitors, continuous glucose monitors, cardiac monitoring devices, smart infusion systems, respiratory therapy devices, implantable-device communication platforms, wearable clinical sensors, selected connected diagnostic equipment, and cloud-integrated therapeutic devices. Generic cloud infrastructure, standalone EHR software, non-medical consumer wellness products, and cloud applications without a connected medical-device component are excluded from the core market estimate.

The market has expanded rapidly from approximately USD 24.40 billion in 2021 to USD 39.30 billion in 2024, reflecting the normalization of remote care following the pandemic, growing integration of bedside equipment with hospital networks, increased adoption of continuous glucose monitoring and ambulatory cardiac monitoring, and wider use of cloud platforms for device fleet management and clinical surveillance. The market reached USD 46.20 billion in 2025 as connected-device purchasing increasingly moved from isolated departmental projects toward enterprise architecture decisions involving clinical engineering, cybersecurity, nursing operations, information technology, and value-analysis teams.

Cloud connectivity is changing the economics of the U.S. medical-device industry. Historically, value was concentrated in the physical device and its consumables. Increasingly, manufacturers are monetizing a broader lifecycle that includes the device, connectivity layer, remote software, analytics, cybersecurity maintenance, data storage, interoperability, technical support, and recurring service contracts. This transition is particularly important for medtech companies seeking predictable recurring revenue and deeper integration into health-system workflows.

The underlying U.S. care infrastructure provides substantial scale for deployment. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, large integrated delivery networks, thousands of ambulatory facilities, extensive physician-practice infrastructure, and a rapidly expanding home-monitoring ecosystem. At the same time, Medicare remote patient monitoring payments exceeded USD 500 million in 2024, indicating that connected devices are moving beyond experimental digital-health programs into reimbursed clinical workflows.

The strongest commercial opportunities through 2035 will arise where device connectivity produces measurable operational or clinical value. Health systems are unlikely to pay a premium merely because a device connects to the cloud. They will pay when connectivity eliminates manual documentation, enables earlier intervention, reduces alarm-management burden, lowers device downtime, supports remote specialist coverage, improves medication safety, facilitates discharge to the home, reduces avoidable utilization, or makes large device fleets easier to manage.

Cloud-connected medical devices are therefore becoming a foundational infrastructure layer rather than an isolated technology category. Their strategic importance will increase as U.S. healthcare moves toward distributed care, hospital-at-home models, ambulatory treatment, virtual nursing, continuous monitoring, algorithm-supported clinical decisions, and longitudinal chronic-disease management.

 

Introduction

According to the U.S. Cloud-Connected Medical Devices Market Report, connectivity is becoming embedded in the design architecture of modern medical devices rather than offered as an optional feature. Medical-device procurement is gradually shifting from product-centric buying toward platform-centric buying in which hospitals consider how devices communicate with clinical applications, electronic medical records, command centers, remote monitoring teams, cybersecurity systems, and enterprise data environments.

This transition has important consequences for both manufacturers and healthcare providers. A traditional bedside monitor generates clinical measurements within a room. A cloud-connected monitor can potentially distribute selected data across clinical teams, enable centralized surveillance, support longitudinal analytics, automate documentation, facilitate software updates, and provide fleet-level visibility. Similarly, a conventional implanted cardiac device provides therapy to an individual patient, while a connected implant ecosystem can also support remote device interrogation, alerts, clinician review, and population-level management.

The U.S. market is particularly well positioned for this transformation because of its combination of high healthcare expenditure, sophisticated hospital IT infrastructure, large chronic-disease populations, mature device reimbursement, extensive smartphone and broadband use, and substantial investment by global medtech manufacturers. Approximately nine in ten U.S. hospitals enabled patients to access health information through application programming interfaces in 2024, while about two-thirds supported some form of patient-generated health-data submission. This interoperability foundation materially improves the commercial environment for devices designed to deliver clinically usable data outside traditional hospital walls.

Demand also reflects persistent pressure on U.S. healthcare labor. Hospitals and physician practices are being asked to monitor larger patient populations while controlling staffing costs and reducing administrative workload. Cloud connectivity creates value when data can be collected automatically rather than manually entered, when clinically relevant changes can be prioritized rather than requiring continuous human surveillance, and when specialist expertise can be distributed across multiple facilities.

Remote patient monitoring is an important part of this shift. Medicare recognizes connected devices capable of automatically collecting and transmitting physiological information for remote monitoring of acute and chronic conditions. Connected blood pressure devices, weight scales, glucose monitors, pulse oximeters, cardiac sensors, respiratory monitors, and other clinical devices increasingly form part of structured care-management programs rather than simple consumer self-tracking.

The U.S. market also has an unusually important cybersecurity dimension. Internet-connected medical devices can create clinical and operational advantages, but connectivity introduces software vulnerabilities, network dependencies, identity-management requirements, update obligations, and potential attack surfaces. Federal law now imposes explicit cybersecurity requirements on qualifying cyber devices submitted for FDA review, including vulnerability-management planning, processes for updates and patches, and software bills of materials. Cybersecurity capability is therefore moving from an IT-support consideration to a core medtech product-development competency.

From 2026 through 2035, competitive differentiation will increasingly depend on whether manufacturers can convert connectivity into a complete clinical operating model. The winners will not necessarily be companies with the largest number of connected devices. They will be those capable of delivering reliable hardware, secure cloud architecture, high-quality data, actionable alerts, workflow integration, interoperability, remote technical management, and evidence demonstrating better outcomes or lower cost.

 

Key Market Drivers: What’s Fueling the U.S. Cloud-Connected Medical Devices Market Boom?

The first major driver is the expansion of remote patient monitoring and longitudinal disease management. Chronic conditions such as diabetes, hypertension, heart failure, arrhythmias, chronic respiratory disease, obesity-related disorders, and sleep apnea require repeated measurement rather than occasional clinical assessment. Cloud-connected devices enable physicians to receive data generated between office visits and potentially identify deterioration before it results in an emergency department encounter or hospitalization.

Medicare coverage has provided an important commercialization framework. Remote physiologic monitoring can involve FDA-defined internet-connected medical devices that automatically transmit data to healthcare providers. Medicare payments for remote patient monitoring surpassed USD 500 million in 2024, demonstrating meaningful provider adoption. This reimbursement environment supports demand not only for standalone devices but also for platforms that manage enrollment, device logistics, data transmission, exception-based review, and clinical documentation.

The second driver is hospital workflow automation. U.S. hospitals continue to face nursing shortages, clinician burnout, documentation burden, and increasing patient acuity. Connected medical devices can reduce manual transcription of vital signs, infusion parameters, diagnostic information, and device status. Smart infusion pumps integrated with medical records, connected vital-sign monitors, centralized telemetry platforms, cloud-based device management, and remote surveillance systems can reduce redundant work and improve information availability.

For procurement committees, the economic value can exceed the purchase price of the device. A device that saves nursing minutes on every patient interaction, reduces programming errors, allows software upgrades without physical service calls, or enables centralized monitoring across hundreds of beds can produce meaningful operating leverage. As a result, connectivity is increasingly evaluated through total cost of ownership and total workflow impact.

The third driver is the rapid expansion of continuous and wearable clinical monitoring. Continuous glucose monitoring has demonstrated that patients, clinicians, payers, and manufacturers can all benefit from a device-plus-data ecosystem. Similar models are emerging in ambulatory ECG monitoring, blood pressure measurement, pulse oximetry, sleep monitoring, neurologic monitoring, and post-operative surveillance. The FDA continues to authorize wearable sensor-based digital health technologies intended for clinical monitoring outside conventional care facilities.

Wearable medical devices also improve the addressable market by shifting monitoring from episodic encounters to continuous or high-frequency measurement. This expands the number of data-generating days per patient and creates recurring opportunities for sensors, software services, analytics, and clinician engagement.

A fourth driver is health-system interoperability maturity. In 2024, approximately 90% of hospitals enabled application-based access to patient information, and standards-based APIs have become increasingly common. This does not mean device interoperability is solved. Medical-device data can still be difficult to normalize and integrate. However, hospital investment in APIs, FHIR-based architecture, enterprise integration engines, identity management, and cloud services reduces the structural barriers to deploying connected devices.

Manufacturers able to integrate with leading EHR environments, support established interoperability standards, and reduce custom integration requirements will gain an advantage. Health systems increasingly prefer scalable enterprise deployments over device-by-device interfaces that create long-term maintenance costs.

A fifth driver is the growth of hospital-at-home, post-acute monitoring, and virtual care. The geographic boundary of the hospital is becoming less important for selected clinical services. Connected blood pressure monitors, weight scales, ECG sensors, pulse oximeters, glucose monitors, digital stethoscopes, respiratory devices, and multi-parameter wearables can extend clinical observation into a patient’s home.

The commercial opportunity is particularly attractive when connected devices enable earlier discharge or substitute for a higher-cost setting of care. The strongest business models are therefore likely to focus on pathways where the device can influence an expensive outcome, such as heart-failure readmission, uncontrolled diabetes, post-operative complications, arrhythmia detection, respiratory deterioration, or medication-related adverse events.

A sixth driver is the migration of medtech companies toward recurring-revenue models. Cloud connectivity allows manufacturers to supplement hardware revenue with software licenses, remote monitoring services, analytics modules, enterprise subscriptions, cybersecurity services, device-management capabilities, and ongoing technical support. This can strengthen customer retention because switching vendors becomes more difficult once devices are integrated into clinical and data workflows.

A seventh driver is AI-enabled interpretation of medical-device data. The FDA’s growing list of AI-enabled devices illustrates how algorithms are moving into radiology, cardiovascular diagnostics, ultrasound, monitoring, and other specialties. Cloud architecture allows manufacturers to aggregate device information, perform computationally intensive analytics, update software more efficiently, and distribute decision-support capabilities across multiple care locations. Over time, AI will increase the value of connected devices by converting raw measurements into prioritization, prediction, and clinical workflow support.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in cloud-connected medical devices is shifting from simple data transmission toward closed-loop information architecture. A first-generation connected device might upload measurements to a portal. Newer systems are being designed to collect information continuously, analyze trends, prioritize abnormalities, distribute alerts, integrate selected information into the EHR, and provide remote configuration or lifecycle support.

Continuous glucose monitoring represents one of the most mature examples. Newer CGM platforms provide longer sensor wear, automatic smartphone delivery of glucose measurements, cloud-enabled sharing, alerts, integration with insulin-delivery technology, and data-analysis tools for patients and clinicians. The introduction of longer-duration sensors improves convenience while reducing the number of sensor replacements required during a year.

Cardiac monitoring is another major innovation area. Connected implantable cardiac devices, loop recorders, wearable ECG patches, telemetry systems, and mobile monitoring platforms increasingly transmit information to remote clinical teams. The commercial value extends beyond detection of arrhythmias. Manufacturers can create ongoing relationships with cardiac practices through monitoring platforms, device clinics, diagnostic services, and longitudinal data.

Hospital monitoring is evolving toward centralized surveillance. Instead of requiring every signal to be reviewed only at the bedside, connected monitoring architectures can route selected information to command centers, specialist workstations, mobile clinician devices, and remote-care teams. This architecture is relevant to intensive care, general wards, emergency care, perioperative monitoring, neonatal care, and virtual nursing.

Smart medication management is emerging as another high-value connected ecosystem. Infusion pumps, automated medication dispensing systems, pharmacy automation, barcode systems, medication-management software, and EHR integration can increasingly operate as components of a connected medication pathway. BD, for example, introduced a cloud-based connected-care platform designed to bring data from its device portfolio into a unified environment, while Baxter continues to expand connected monitoring and smart infusion integration.

Device fleet management is becoming strategically important for large health systems. Hospitals can operate thousands or tens of thousands of network-connected medical assets. Cloud-based fleet tools can help clinical engineering teams understand software versions, connectivity status, utilization, battery status, service requirements, and potentially cybersecurity posture. This capability can materially change capital planning by providing better visibility into which devices are being used, underused, or approaching replacement.

Imaging devices are also moving toward cloud-connected architectures. Large diagnostic systems have traditionally relied heavily on local infrastructure because medical images require substantial storage and processing capacity. New cloud-first and hybrid architectures can allow health systems to centralize archives, make images available across locations, deploy AI applications more efficiently, and reduce some on-premise IT requirements. GE HealthCare’s cloud strategy and its Genesis enterprise imaging portfolio illustrate the broader shift toward recurring cloud-enabled medtech models.

Cybersecurity has itself become an innovation category. Manufacturers now need secure-by-design development, vulnerability monitoring, coordinated disclosure programs, software-component inventories, patching processes, authentication, encryption, access controls, logging, and lifecycle support. These capabilities can become commercial differentiators because hospital CISOs and clinical engineering departments increasingly evaluate device cybersecurity before enterprise deployment.

The next innovation cycle will involve edge-cloud orchestration. Not every function should depend on a cloud connection. Safety-critical functions generally require reliable local operation even when connectivity is interrupted. Leading architectures will therefore perform immediate control functions at the device or edge layer while using the cloud for analytics, fleet management, population monitoring, historical trends, updates, and cross-site visibility. This balance between local resilience and cloud intelligence will be central to next-generation product design.

 

Segmentation Insights

The U.S. Cloud-Connected Medical Devices Market is segmented on the basis of device category, connectivity technology, application, end user, and region.

 

By Device Category

Connected Patient Monitoring Devices

Connected patient monitoring represents the largest device category, accounting for an estimated 29.5% of the U.S. market in 2025, equivalent to approximately USD 13.63 billion. Subsegments include multi-parameter bedside monitors, wearable vital-sign sensors, pulse oximeters, connected blood pressure monitors, temperature monitoring systems, telemetry devices, capnography systems, maternal-fetal monitoring systems, and mobile surveillance devices.

Demand is driven by inpatient monitoring, virtual nursing, hospital-at-home programs, emergency care, post-operative monitoring, and chronic-disease management. Hospitals increasingly prefer monitoring platforms that can aggregate information across beds, units, and facilities rather than isolated devices that create additional alarm silos.

Diabetes and Metabolic Monitoring Devices

Diabetes and metabolic devices accounted for approximately 20.0% of the market in 2025, or about USD 9.24 billion. Key subsegments include continuous glucose monitors, connected blood glucose meters, smart insulin-delivery interfaces, connected insulin pumps, and metabolic monitoring technologies.

This category has one of the strongest recurring-revenue characteristics because sensors and consumables are replaced frequently and patients generate continuous data. Integration among CGM, insulin delivery, smartphones, cloud applications, clinicians, and caregivers makes diabetes one of the most advanced examples of a connected medical-device ecosystem.

Connected Cardiovascular and Implantable Devices

Connected cardiovascular and implantable devices represented approximately 18.0% of 2025 revenue, or USD 8.32 billion. Subsegments include pacemakers and defibrillators with remote follow-up, implantable loop recorders, ambulatory ECG devices, mobile cardiac telemetry, connected hemodynamic monitors, wearable defibrillators, and cloud-enabled cardiac diagnostic systems.

The segment benefits from the clinical importance of timely arrhythmia detection and the large installed base of patients requiring long-term follow-up. Remote interrogation can reduce unnecessary in-person checks and allow device clinics to manage larger patient populations.

Connected Therapeutic and Infusion Devices

Connected therapeutic and infusion devices accounted for approximately 17.0% of the 2025 market, equivalent to USD 7.85 billion. Subsegments include smart infusion pumps, insulin pumps, respiratory therapy devices, ventilatory support devices, sleep apnea equipment, dialysis-related connected systems, and other therapy platforms capable of transmitting operating or treatment data.

Hospital adoption is increasingly linked to interoperability. Smart pumps integrated with EHRs can support auto-programming, documentation, drug-library management, and safety workflows. Connected respiratory devices and home-therapy platforms create recurring value through adherence information and remote patient management.

Connected Diagnostic, Imaging and Other Medical Devices

Connected diagnostic, imaging, and other devices represented approximately 15.5% of the market in 2025, or about USD 7.16 billion. Subsegments include cloud-connected ultrasound, portable imaging, electrocardiography, point-of-care diagnostics, diagnostic sensors, selected laboratory devices, digital examination tools, and connected specialty equipment.

This category is expected to gain importance as manufacturers move image management, AI deployment, remote technical support, and cross-site diagnostic workflows into cloud environments.

 

By Connectivity Technology

Wi-Fi and Enterprise Wireless Connectivity

Wi-Fi and enterprise wireless networks represent the largest connectivity technology segment, accounting for approximately 32% of 2025 market value. Wi-Fi is heavily used for inpatient monitoring, infusion systems, diagnostic equipment, smart beds, mobile hospital devices, and other equipment operating within controlled healthcare environments.

Hospitals value Wi-Fi because it can support high-bandwidth transmission and existing enterprise networks, but medical-device traffic also creates challenges related to network segmentation, authentication, roaming, coverage, quality of service, and cybersecurity.

Bluetooth and Bluetooth Low Energy

Bluetooth and Bluetooth Low Energy represented approximately 30% of the market. Subsegments include smartphone-connected CGMs, wearable ECG devices, home monitoring sensors, mobile cardiac devices, portable diagnostic equipment, and patient-generated health technologies.

Bluetooth is particularly important for devices that use a smartphone or dedicated hub as an intermediary before transmitting information to the cloud. Low-energy architecture supports smaller devices and longer battery life, making it attractive for continuous wearable monitoring.

Cellular Connectivity

Cellular connectivity accounted for approximately 22% of 2025 market value. Subsegments include embedded LTE and 5G devices, dedicated cellular gateways, implantable-device communicators, mobile telemetry, and home monitoring systems.

Cellular connections are valuable when the manufacturer or provider wants to reduce dependence on patient Wi-Fi configuration. This can improve deployment reliability for older adults and high-risk patients. As 5G coverage matures, cellular connectivity will become more important for mobile clinical workflows and bandwidth-intensive applications.

5G and Low-Power Wide-Area Connectivity

5G and LPWAN technologies represented approximately 9% of market value in 2025 but are expected to grow rapidly. These technologies can support large device densities, improved mobility, lower latency, campus-wide connectivity, and selected low-power applications.

Private 5G networks may become relevant for large hospitals and medical campuses that require more control over network performance and security, although broad clinical adoption will depend on total infrastructure economics.

NFC, Wired-to-Cloud Gateways and Other Connectivity

Other connectivity technologies accounted for approximately 7% of the market. This segment includes near-field communication, proprietary radio systems, Ethernet-linked medical equipment connected through cloud gateways, and hybrid architectures. These approaches remain important for specialized devices and installed equipment that cannot immediately migrate to fully wireless architectures.

 

By Application

Chronic Disease Monitoring and Management

Chronic-disease monitoring represented approximately 35% of 2025 market value, making it the largest application. Major subsegments include diabetes, cardiovascular disease, hypertension, respiratory disease, sleep disorders, obesity-related conditions, and multi-morbidity monitoring.

The recurring nature of chronic disease makes connectivity economically attractive. The value is created not merely by collecting measurements but by creating a continuous management pathway involving patient engagement, clinical review, automated escalation, and longitudinal outcomes assessment.

Acute and Continuous Patient Monitoring

Acute and continuous patient monitoring accounted for approximately 24% of the market. Subsegments include ICU monitoring, general ward surveillance, emergency care, perioperative monitoring, neonatal monitoring, and centralized telemetry.

Growth will be driven by hospital staffing pressures and virtual-care models. Health systems are evaluating architectures that enable experienced clinicians to monitor multiple beds or hospitals from centralized locations, improving the leverage of scarce nursing and specialist resources.

Connected Therapy and Medication Delivery

Connected therapy and medication delivery represented approximately 18% of the market. Subsegments include infusion therapy, insulin delivery, respiratory therapy, sleep therapy, dialysis support, and adherence-enabled treatment devices.

This application is strategically attractive because device connectivity can directly affect treatment delivery rather than merely observe the patient. As a result, reliability, cybersecurity, integration, and failure-mode management are particularly important.

Diagnostic and Clinical Decision Support

Diagnostic applications accounted for approximately 14% of the 2025 market. Subsegments include cardiac diagnostics, imaging, point-of-care testing, connected ultrasound, remote examination, neurologic diagnostics, and cloud-assisted interpretation.

The segment is increasingly influenced by AI. Connected diagnostic devices can send information to cloud-based algorithms, specialist networks, and enterprise applications, potentially allowing faster interpretation and broader access to expertise.

Post-Acute, Home and Rehabilitation Monitoring

Post-acute, rehabilitation, and home monitoring represented approximately 9% of market value but is expected to be one of the fastest-growing applications. Subsegments include hospital-at-home monitoring, post-operative surveillance, rehabilitation monitoring, transitional care, skilled nursing monitoring, and home recovery programs.

Growth will depend on whether providers can demonstrate that monitoring reduces readmissions, emergency utilization, or length of stay sufficiently to justify program costs.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems are the dominant end users, accounting for approximately 46% of 2025 market revenue. Large integrated delivery networks increasingly make enterprise purchasing decisions covering device hardware, interfaces, cloud services, cybersecurity, analytics, service contracts, and implementation.

The purchasing process is multidisciplinary. Clinical users evaluate accuracy and workflow; IT teams evaluate interoperability and network architecture; cybersecurity teams assess risk; clinical engineering evaluates serviceability and fleet management; finance assesses lifecycle economics; and value-analysis committees examine clinical evidence.

Ambulatory Centers and Physician Practices

Ambulatory facilities and physician practices represented approximately 20% of market demand. Subsegments include cardiology practices, endocrinology clinics, primary care practices, ambulatory surgery centers, specialty clinics, and office-based diagnostic facilities.

These customers generally require lower implementation complexity than large hospitals. Cloud-native platforms are attractive because they can reduce the need for local servers and dedicated IT staff.

Home Healthcare and Remote Monitoring Providers

Home healthcare and RPM providers accounted for approximately 21% of 2025 revenue and represent the fastest-growing end-user category. These organizations deploy connected devices across geographically distributed patient populations and therefore require reliable onboarding, automated transmission, patient support, clinician dashboards, alert workflows, logistics management, and payer documentation.

Device usability is critical. A technically sophisticated product that requires complicated Wi-Fi configuration or frequent troubleshooting may produce poor economics in a large home-monitoring program.

Long-Term Care and Post-Acute Facilities

Long-term care, rehabilitation, skilled nursing, and post-acute providers accounted for approximately 8% of the market. Connected monitoring can help these organizations identify deterioration, reduce avoidable transfers, and support physicians who are not continuously present on site.

Diagnostic and Specialty Care Providers

Diagnostic laboratories, imaging centers, sleep centers, specialty monitoring organizations, and other providers represented approximately 5% of market value. Cloud connectivity allows these organizations to centralize interpretation, route information to specialists, coordinate multi-location operations, and create service-based diagnostic models.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Cloud-Connected Medical Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population scale, hospital-system concentration, digital-health investment, chronic-disease burden, Medicare exposure, academic medical-center density, broadband infrastructure, venture activity, and adoption of remote care.

The South is the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast remains highly influential for academic adoption, enterprise health-system deployment, and clinical validation. The Midwest provides a large, durable base of hospital-connected devices and offers strong opportunities for remote monitoring across mixed urban and rural populations.

South

The South represented an estimated USD 15.52 billion in 2025, accounting for approximately one-third of the national market. It is projected to reach approximately USD 73.54 billion by 2035, representing a CAGR of about 16.83%.

The regional state mapping includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, West Virginia, Kentucky, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and the District of Columbia within the broader commercial territory commonly used for U.S. healthcare analysis.

Texas is one of the most important state markets nationally. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major hospital networks, academic institutions, specialty providers, and growing digital-health ecosystems. Large integrated health systems can support enterprise deployment of connected patient monitoring, smart infusion, remote cardiac care, CGM, hospital-at-home technologies, and connected diagnostic equipment.

Florida represents another major opportunity because of its large older-adult population and high Medicare exposure. Cloud-connected cardiac monitoring, diabetes technology, respiratory devices, sleep therapy, blood pressure monitoring, heart-failure monitoring, and post-acute care solutions are particularly relevant. The state’s large outpatient and senior-care infrastructure supports migration of monitoring beyond hospital walls.

North Carolina has a strong combination of academic medicine, life sciences, healthcare technology, and rapidly expanding metropolitan populations. Georgia and Tennessee are also important because Atlanta and Nashville serve as major healthcare corporate and delivery hubs. These states are attractive launch markets for enterprise connected-care platforms because vendors can engage sophisticated health systems while accessing broader regional networks.

Virginia and Maryland benefit from advanced provider systems, federal healthcare influence, research institutions, and dense suburban markets. Connected diagnostics, cybersecurity-sensitive medical systems, remote monitoring, and data interoperability are important commercial categories.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have smaller absolute device markets but high burdens of cardiovascular disease, diabetes, obesity, and other chronic conditions. These states create a strong clinical rationale for remote monitoring, especially where specialist availability is limited.

Rural connectivity remains a constraint in parts of the South. Manufacturers that offer cellular-enabled devices, simplified patient onboarding, offline buffering, and flexible connectivity can be better positioned than platforms requiring technically complex home Wi-Fi installations.

The South is expected to remain the largest regional market through 2035 because it combines population growth, chronic-disease intensity, health-system expansion, home-monitoring need, and a large Medicare population. Texas and Florida will remain the principal state opportunities, while North Carolina, Georgia, Tennessee, and Virginia are expected to record particularly strong enterprise adoption.

West

The West represented approximately USD 12.01 billion in 2025 and is projected to reach around USD 61.68 billion by 2035, corresponding to an estimated 17.78% CAGR, the fastest among the four U.S. regions.

The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest market in the West and one of the most strategically important connected-medical-device markets globally. The state combines an enormous patient population with major academic medical centers, integrated delivery networks, digital-health companies, cloud infrastructure expertise, semiconductor capabilities, software talent, venture capital, and a strong medical-technology industry.

California health systems are attractive early adopters of AI-enabled monitoring, enterprise imaging, remote specialty care, connected diabetes devices, wearable biosensors, and virtual-care infrastructure. The state’s technology ecosystem also makes it an important proving ground for partnerships between medical-device companies, software developers, cloud providers, and health systems.

Washington is important because of its cloud-computing ecosystem and sophisticated provider organizations. The presence of major technology infrastructure companies indirectly supports development and deployment of cloud-native healthcare solutions. Oregon has a smaller population but a mature integrated-care environment conducive to remote monitoring and population-health programs.

Arizona and Nevada are among the most attractive demographic growth markets. Rapid population growth and increasing numbers of older residents support demand for cardiovascular monitoring, diabetes technologies, respiratory care, hospital capacity, and home-based disease management.

Colorado and Utah combine expanding populations with strong healthcare networks, technology adoption, and growing digital-health ecosystems. These states are well positioned for wearable clinical monitoring, ambulatory diagnostics, virtual specialty care, and cloud-connected home health.

Idaho, Montana, Wyoming, Alaska, and New Mexico have lower absolute market values but offer a compelling connectivity use case because patients can be located far from tertiary medical centers. Cellular-enabled monitoring, remote diagnostics, and specialist-access technologies can create disproportionate clinical value in geographically dispersed populations.

Hawaii presents similar distance-related care challenges within an island geography, creating demand for connected devices that can support remote specialist review and chronic-disease management without requiring frequent travel.

The West is expected to gain national share through 2035 because its provider organizations frequently adopt digital care models early, its technology ecosystem supports rapid innovation, and its fast-growing states are expanding healthcare infrastructure. Manufacturers seeking early commercial validation for cloud-native device models will continue to prioritize California, Washington, Arizona, Colorado, and Utah.

Northeast

The Northeast accounted for an estimated USD 10.21 billion in 2025 and is projected to reach approximately USD 47.24 billion by 2035, representing a CAGR of about 16.55%.

The regional mapping includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, Vermont, and New Hampshire. Delaware may be commercially grouped with either the Northeast or South depending on the vendor’s territory structure; in this report it is incorporated into the South to maintain mutually exclusive regional estimates.

New York represents the largest state market in the Northeast. Its combination of population density, large academic systems, extensive specialty networks, home-care organizations, and complex hospital infrastructure creates significant demand for inpatient connectivity, cardiac monitoring, diabetes technology, smart medication management, and remote patient management.

Massachusetts is disproportionately influential relative to population size. Boston’s academic hospitals, biotechnology cluster, medical-device community, clinical research infrastructure, and digital-health ecosystem make the state an important early-adoption and evidence-generation market. Manufacturers often use leading Massachusetts institutions to validate new monitoring workflows before pursuing broader national rollout.

Pennsylvania has a large and diversified care-delivery infrastructure that spans major academic systems, community hospitals, rural areas, and large physician networks. This creates opportunities across both enterprise-connected devices and remote monitoring. New Jersey similarly benefits from dense healthcare infrastructure, pharmaceutical and medical-technology activity, and close integration with the New York metropolitan healthcare economy.

Connecticut and Rhode Island offer smaller but sophisticated provider markets. Maine, Vermont, and New Hampshire are attractive for remote monitoring because specialist access and travel distances can create a strong case for connected care.

The Northeast has some of the country’s most demanding hospital technology buyers. Academic institutions and large health systems frequently require strong clinical evidence, interoperability documentation, cybersecurity review, implementation support, and demonstrated integration with existing enterprise systems.

Growth is likely to remain slightly below the West because the region has slower population expansion and relatively mature hospital infrastructure. However, revenue per deployment can be high because Northeast institutions are significant purchasers of premium monitoring, diagnostic, and digitally integrated medical technologies.

Midwest

The Midwest represented approximately USD 8.46 billion in 2025 and is expected to reach around USD 37.84 billion by 2035, reflecting an estimated 16.16% CAGR.

The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest regional opportunity due to Chicago’s concentration of academic medical centers, large hospital systems, specialty providers, and healthcare companies. Connected hospital monitoring, medication-management systems, ambulatory cardiac devices, and enterprise medical-device connectivity are important categories.

Ohio has a particularly strong health-system environment, including nationally prominent specialty and academic institutions. Large integrated networks provide attractive opportunities for enterprise deployment, clinical validation, virtual specialty care, and connected chronic-disease management.

Michigan supports substantial demand for cardiac, diabetes, respiratory, and hospital monitoring technologies. Minnesota is strategically important because of its established medtech ecosystem and deep expertise in cardiovascular devices, monitoring technologies, and medical innovation. The state also offers strong opportunities for partnerships between manufacturers and sophisticated health systems.

Indiana, Wisconsin, and Missouri have large community-hospital and regional referral networks. Connected devices that improve standardization across multi-hospital systems can be particularly attractive because centralized procurement can extend a successful deployment across multiple facilities.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota illustrate one of the strongest strategic use cases for cloud-connected devices: extending clinical observation across geographic distance. Rural hospitals frequently lack continuous access to specialist expertise. Connected diagnostics, cardiac monitoring, remote vital-sign surveillance, and cloud-enabled device data can support regional care networks in which specialists manage patients across multiple locations.

The Midwest is expected to grow more slowly than the West and South but remains a strategically durable market. Manufacturers that offer reliable integration, strong field service, practical economic justification, and connectivity that works across urban and rural care environments can build substantial long-term positions.

Across all four regions, the national opportunity will increasingly shift from simply selling connected hardware to achieving enterprise standardization. Winning a large integrated delivery network can create a multi-year device refresh, software, service, and data-management relationship. Consequently, regional strategy must consider not only state population but also health-system concentration, referral patterns, EHR environments, remote-care maturity, purchasing organizations, and clinical leadership networks.

 

Key Market Players

The U.S. Cloud-Connected Medical Devices competitive landscape is moderately consolidated at the platform level but fragmented across individual clinical applications. Large medtech manufacturers benefit from installed hospital-device bases, service organizations, regulatory expertise, enterprise contracts, and the ability to integrate hardware with software. Specialist companies remain highly competitive in categories such as continuous glucose monitoring, ambulatory cardiac monitoring, wearable biosensors, insulin delivery, and remote patient management.

Some of the key players in the U.S. Cloud-Connected Medical Devices industry include Abbott Laboratories, Medtronic, Dexcom, GE HealthCare, Philips Healthcare, Baxter International, Becton Dickinson and Company, Masimo, ResMed, Boston Scientific, iRhythm Technologies, Insulet Corporation, Tandem Diabetes Care, Edwards Lifesciences, BIOTRONIK, ZOLL Medical, Omron Healthcare, Nihon Kohden, Dräger, ICU Medical, Fresenius Kabi, AliveCor, BioIntelliSense, VitalConnect, and Empatica.

Abbott and Dexcom hold particularly strong positions in connected diabetes management, where sensor-generated data, mobile applications, cloud sharing, and therapy integration create highly developed device ecosystems. Insulet and Tandem participate in connected insulin-delivery workflows that increasingly interact with CGM systems.

Medtronic combines connected implantable cardiac-device monitoring, diabetes technology, and multiple therapeutic device platforms. Its CareLink ecosystem illustrates how implant manufacturers can build ongoing digital relationships with clinical device-management teams.

GE HealthCare and Philips occupy influential positions in connected patient monitoring, imaging, diagnostic equipment, AI-enabled medical devices, and enterprise clinical infrastructure. Their installed hospital equipment bases provide opportunities to extend cloud platforms across multiple clinical departments.

Baxter and BD are important competitors in connected hospital workflows. Baxter’s portfolio spans infusion, monitoring, smart beds, communication systems, and cloud-enabled connectivity. BD’s connected-care strategy integrates medication-management devices and increasingly uses cloud-based analytics to unify device information across enterprise environments.

Masimo participates in hospital and remote monitoring through connected pulse oximetry, wearable technologies, centralized surveillance, and cloud-based remote patient management. ResMed has built one of the most established cloud-connected device models in respiratory and sleep care through remotely managed positive-airway-pressure equipment and adherence data.

iRhythm, VitalConnect, AliveCor, and other cardiovascular technology companies are important in ambulatory ECG and connected diagnostic workflows. BioIntelliSense and Empatica represent the growing wearable biosensor segment, where continuous data can support acute, post-acute, clinical-research, and chronic-care applications.

Competition over the next decade will increasingly revolve around platform depth, cybersecurity, interoperability, installed-base leverage, analytics, recurring-revenue capability, clinical evidence, and workflow ownership rather than device specifications alone.

A manufacturer able to connect thousands of devices across an integrated delivery network, maintain software and cybersecurity throughout their lifecycle, integrate data into clinical systems, support remote monitoring, and demonstrate measurable economic outcomes will have significantly greater strategic value than a manufacturer selling an isolated connected endpoint.

 

Recent Developments

Recent developments in the U.S. Cloud-Connected Medical Devices Market indicate that the industry is entering a more mature phase in which connectivity, cloud platforms, cybersecurity, and AI are being designed together.

In February 2026, the FDA issued updated final cybersecurity guidance for medical devices, reinforcing expectations for cybersecurity risk management and documentation associated with connected and software-dependent devices. Manufacturers of qualifying cyber devices face explicit requirements related to vulnerability monitoring, secure development, software-component visibility, and post-market updates. This changes device economics because cybersecurity must now be funded throughout the commercial lifecycle rather than treated primarily as a premarket engineering activity.

The FDA has also continued expanding transparency around sensor-based digital health technologies. Devices authorized during 2025 and 2026 include connected cardiovascular, glucose, neurological, sleep, and wearable monitoring technologies. This demonstrates the growing regulatory normalization of clinical-grade sensing outside traditional hospital environments.

In April 2025, Dexcom received U.S. FDA clearance for its Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes. The system extended wear duration to approximately 15.5 days and subsequently entered the U.S. market, highlighting competition around sensor longevity, accuracy, patient convenience, connectivity, and data-enabled diabetes management.

In March 2025, GE HealthCare announced its Genesis cloud enterprise imaging portfolio. The initiative reflects a broader medtech transition toward cloud-enabled product portfolios and recurring software revenue. GE HealthCare has publicly identified expansion of cloud-enabled offerings as a strategic priority, illustrating how major equipment manufacturers are increasingly linking capital equipment with cloud-based service models.

In September 2025, Baxter launched the Welch Allyn Connex 360 Vital Signs Monitor, designed to connect through the company’s cloud-based DeviceBridge platform and support transfer of vital-sign data into hospital information systems. The product demonstrates how traditional bedside monitoring is evolving toward connected documentation, upgradeable software, security, and enterprise interoperability.

In October 2025, BD introduced the Incada Connected Care Platform, a scalable cloud-based platform designed to unify information from connected BD devices. The company indicated that its installed environment includes nearly three million smart connected devices, demonstrating the scale at which large medtech manufacturers can generate device data across medication-management and hospital workflows.

Connected infusion therapy is also moving toward deeper integration. Real-world analysis involving more than one million infusions has demonstrated how smart pump-EHR integration can reduce aspects of programming and alert-management workload. This type of evidence is strategically important because hospitals increasingly expect connected-device vendors to quantify workflow benefit rather than simply demonstrate technical connectivity.

Cybersecurity events continue to shape procurement. Vulnerabilities reported in remote cardiac monitoring infrastructure and corrective actions involving connected medical devices have reinforced the importance of patching, software support, network segmentation, vulnerability disclosure, and vendor responsiveness. Hospital procurement teams are therefore assigning greater weight to lifecycle cybersecurity performance.

Remote patient monitoring continues to expand commercially. Medicare payments exceeded USD 500 million in 2024, while federal policy continues to recognize internet-connected FDA medical devices as a central component of remote physiologic monitoring. This reimbursement foundation is supporting broader deployment across hypertension, diabetes, cardiovascular disease, respiratory care, and other conditions.

The combination of these developments indicates that the next competitive phase will be defined by integration rather than connectivity alone. Cloud connection is becoming expected. The differentiating question is whether the manufacturer can securely transform device-generated information into clinically relevant action at scale.

 

Conclusion

The U.S. Cloud-Connected Medical Devices Market Size & Share is positioned for substantial expansion from approximately USD 46.20 billion in 2025 to USD 220.30 billion by 2035, representing an aggressive 16.91% CAGR during 2026–2035. Historical market value increased from approximately USD 24.40 billion in 2021 to USD 39.30 billion in 2024 as U.S. healthcare moved rapidly toward connected monitoring, remote disease management, smart medication delivery, cloud-enabled diagnostics, and device-generated clinical data.

The market’s long-term strength is grounded in structural rather than temporary factors. U.S. hospitals operate at enormous scale, chronic disease requires continuous management, Medicare has established reimbursement pathways for remote monitoring, health systems have invested heavily in interoperable digital infrastructure, and medical-device manufacturers increasingly view cloud connectivity as a route to recurring revenue and stronger customer retention.

Connected patient monitoring will remain the largest device category, while cloud-connected diabetes, cardiovascular, therapeutic, and wearable platforms will contribute substantial incremental value. Chronic-disease management will remain the dominant application, but acute monitoring, hospital-at-home care, connected medication delivery, AI-supported diagnostics, and post-acute surveillance will expand rapidly.

Hospitals and integrated delivery networks will remain the largest end users, but the location of device-generated data will increasingly shift toward homes, ambulatory facilities, physician practices, and virtual-care environments. This creates a critical strategic requirement: manufacturers must design devices for distributed healthcare rather than assuming that professional IT support is always available at the point of use.

Regionally, the South is expected to remain the largest market, supported by Texas, Florida, North Carolina, Georgia, Tennessee, and Virginia. The West is projected to grow fastest, driven by California’s technology and health-system ecosystem and rapid expansion in Arizona, Nevada, Colorado, and Utah. The Northeast will remain an important premium and early-adoption region, while the Midwest will provide durable enterprise demand and a strong use case for connected care across geographically dispersed populations.

The competitive landscape will increasingly favor companies capable of combining medical-grade hardware with secure cloud infrastructure, interoperability, remote monitoring, AI-enabled analytics, lifecycle cybersecurity, and enterprise implementation capabilities. Device manufacturers that remain focused only on physical hardware risk losing strategic control of the workflow to competitors that own the data and software layer.

Cybersecurity will be one of the most important determinants of market access. FDA requirements for connected cyber devices mean vulnerability management, software bills of materials, patching processes, secure product development, and post-market surveillance are becoming fundamental components of commercial readiness. Hospitals are similarly strengthening security reviews before placing connected devices on clinical networks.

For clients evaluating the U.S. Cloud-Connected Medical Devices Market, the critical question is therefore not whether medical devices will become more connected. That transition is already underway. The more important questions are which device categories can generate defensible recurring revenue, which clinical workflows produce measurable economic value, which manufacturers can achieve enterprise standardization, which platforms can integrate safely with health-system infrastructure, and where connected devices can shift care into lower-cost settings without compromising clinical quality.

From 2026 through 2035, the highest-value companies will be those that transform connectivity from a product feature into a clinical operating system. They will combine accurate devices, automated data acquisition, secure transmission, intelligent analytics, workflow integration, remote clinical management, and measurable outcomes. In the U.S. healthcare environment, that combination will increasingly define the difference between a connected medical device and a strategically indispensable medtech platform.

 

TABLE OF CONTENT

1. U.S. Cloud-Connected Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Cloud-Connected Medical Device Manufacturers
1.6.2. Medical Sensor, Semiconductor and Connectivity Component Suppliers
1.6.3. Cloud Infrastructure and Medical Device Connectivity Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Ambulatory, Specialty and Physician-Based Care Providers
1.6.6. Home Healthcare and Remote Patient Monitoring Providers
1.6.7. Group Purchasing Organizations, Distributors and Channel Partners
1.6.8. Payers, Regulators, Cybersecurity Teams and Clinical Decision-Makers

What this section provides: This section defines the U.S. cloud-connected medical devices market boundary, study scope, methodology, assumptions, inclusion and exclusion criteria, and stakeholder ecosystem so clients understand how market revenues are measured and validated.

2. U.S. Cloud-Connected Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. High-Growth Device Categories
2.9. High-Growth Clinical Applications
2.10. Regional Opportunity Hotspots
2.11. Key Investment and Procurement Themes

What this section provides: This section gives executives a concise view of market size, growth trajectory, connected-device adoption, competitive intensity, major demand pockets, fastest-growing applications, and priority commercial opportunities through 2035.

3. U.S. Cloud-Connected Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Remote Patient Monitoring and Chronic Disease Management
3.1.2. Rising Adoption of Connected Patient Monitoring Across U.S. Hospitals
3.1.3. Growth of Continuous Glucose Monitoring and Connected Diabetes Management
3.1.4. Increasing Integration of Medical Devices with EHR and Clinical Information Systems
3.1.5. Expansion of Hospital-at-Home and Virtual Care Models
3.1.6. Growing Demand for Automated Clinical Documentation and Workflow Efficiency
3.1.7. Shift Toward Recurring Software and Device-as-a-Service Revenue Models

3.2. Restraints and Their Impact Analysis
3.2.1. Medical Device Cybersecurity and Data Breach Risks
3.2.2. High Integration and Enterprise Deployment Costs
3.2.3. Legacy Medical Device Interoperability Challenges
3.2.4. Connectivity Reliability and Network Infrastructure Limitations
3.2.5. Alert Fatigue and Clinical Workflow Burden
3.2.6. Patient Digital Access and Home Connectivity Gaps

3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Enabled Medical Device Analytics
3.3.2. Connected Hospital-at-Home Monitoring
3.3.3. Cloud-Based Medical Device Fleet Management
3.3.4. Cellular-Enabled Remote Medical Devices
3.3.5. Smart Infusion and Connected Medication Management
3.3.6. Wearable Clinical-Grade Biosensors
3.3.7. Connected Implantable Medical Device Monitoring
3.3.8. Remote Diagnostics and Virtual Specialty Care

3.4. Challenges and Their Impact Analysis
3.4.1. Cybersecurity Lifecycle Management
3.4.2. Cloud Vendor Dependency and System Resilience
3.4.3. Device Data Standardization
3.4.4. Regulatory Compliance Across Software Update Cycles
3.4.5. Integration with Multi-Vendor Hospital Technology Environments

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Total Cost of Ownership Analysis for Connected Medical Devices
3.9. Remote Monitoring Economics and Reimbursement Impact
3.10. Enterprise Device Standardization Trends

What this section provides: This section explains the clinical, technological, reimbursement, cybersecurity, economic, and operational forces shaping cloud-connected medical device adoption while identifying major upside opportunities and execution risks.

4. U.S. Cloud-Connected Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Sensors and Electronic Components
4.4.2. Medical Device Hardware Manufacturing
4.4.3. Connectivity Modules and Gateways
4.4.4. Cloud Infrastructure and Data Platforms
4.4.5. Clinical Software and Analytics
4.4.6. Distribution, Implementation and Technical Support
4.4.7. Healthcare Provider and Patient Interface

4.5. Impact of Digitalization and Internet of Medical Things
4.6. Medical Device Interoperability Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. FDA Medical Device Classification Considerations
4.7.2. Connected and Software-Enabled Medical Device Requirements
4.7.3. FDA Cyber Device Requirements
4.7.4. Premarket Cybersecurity Documentation
4.7.5. Post-Market Vulnerability and Patch Management

4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Remote Physiologic Monitoring
4.8.2. Remote Therapeutic Monitoring
4.8.3. Chronic Care and Connected Care Economics
4.8.4. Medicare and Commercial Payer Adoption

4.9. HIPAA, Privacy and Protected Health Information Considerations
4.10. Medical Device Cybersecurity Landscape
4.11. EHR, API and FHIR Interoperability Trends
4.12. Cloud Infrastructure and Data Residency Considerations
4.13. Import/Export Restrictions & Tariff Impact
4.14. Semiconductor and Connectivity Component Supply Risk
4.15. Government Digital Health and Broadband Initiatives
4.16. Impact of Escalating Geopolitical Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. Hospital CISO and Clinical Engineering Procurement Influence

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, cybersecurity, interoperability, supply-chain, technology, pricing, and procurement environment affecting connected medical device commercialization in the United States.

5. U.S. Cloud-Connected Medical Devices Market – By Device Category

5.1. Overview
5.1.1. Segment Share Analysis, By Device Category, 2025 & 2035 (%)

5.1.2. Connected Patient Monitoring Devices
5.1.2.1. Multi-Parameter Patient Monitors
5.1.2.2. Connected Pulse Oximeters
5.1.2.3. Connected Blood Pressure Monitors
5.1.2.4. Connected Temperature Monitoring Systems
5.1.2.5. Telemetry and Continuous Vital Sign Monitors
5.1.2.6. Wearable Patient Monitoring Sensors

5.1.3. Diabetes and Metabolic Monitoring Devices
5.1.3.1. Continuous Glucose Monitoring Systems
5.1.3.2. Connected Blood Glucose Meters
5.1.3.3. Connected Insulin Pumps
5.1.3.4. Smart Insulin Delivery Interfaces
5.1.3.5. Other Metabolic Monitoring Devices

5.1.4. Connected Cardiovascular and Implantable Devices
5.1.4.1. Connected Pacemakers
5.1.4.2. Connected Implantable Cardioverter Defibrillators
5.1.4.3. Implantable Loop Recorders
5.1.4.4. Ambulatory ECG and Mobile Cardiac Telemetry Devices
5.1.4.5. Connected Hemodynamic Monitoring Devices
5.1.4.6. Wearable Cardiac Monitoring Devices

5.1.5. Connected Therapeutic and Infusion Devices
5.1.5.1. Smart Infusion Pumps
5.1.5.2. Connected Respiratory Therapy Devices
5.1.5.3. Connected Ventilation Devices
5.1.5.4. Connected Sleep Apnea Therapy Devices
5.1.5.5. Connected Dialysis and Renal Therapy Devices
5.1.5.6. Other Connected Therapeutic Devices

5.1.6. Connected Diagnostic, Imaging and Other Medical Devices
5.1.6.1. Connected Ultrasound Systems
5.1.6.2. Cloud-Connected Imaging Equipment
5.1.6.3. Connected Electrocardiography Systems
5.1.6.4. Connected Point-of-Care Diagnostic Devices
5.1.6.5. Connected Neurological Diagnostic Devices
5.1.6.6. Connected Digital Examination Devices

What this section provides: This section identifies which cloud-connected medical device categories generate the greatest revenue, recurring data value, installed-base opportunity, and growth potential through 2035.

6. U.S. Cloud-Connected Medical Devices Market – By Connectivity Technology

6.1. Overview
6.1.1. Segment Share Analysis, By Connectivity Technology, 2025 & 2035 (%)

6.1.2. Wi-Fi and Enterprise Wireless Connectivity
6.1.2.1. Hospital Wi-Fi Networks
6.1.2.2. Enterprise WLAN Medical Device Connectivity
6.1.2.3. Wi-Fi Direct and Gateway-Based Connectivity

6.1.3. Bluetooth and Bluetooth Low Energy
6.1.3.1. Smartphone-Connected Medical Devices
6.1.3.2. Wearable Sensor Connectivity
6.1.3.3. Home Monitoring Device Connectivity
6.1.3.4. Dedicated Bluetooth Medical Gateways

6.1.4. Cellular Connectivity
6.1.4.1. LTE-Connected Medical Devices
6.1.4.2. Embedded Cellular Medical Devices
6.1.4.3. Cellular Remote Patient Monitoring Gateways
6.1.4.4. Mobile Cardiac and Telemetry Devices

6.1.5. 5G and Low-Power Wide-Area Connectivity
6.1.5.1. Public 5G Networks
6.1.5.2. Private 5G Hospital Networks
6.1.5.3. LTE-M
6.1.5.4. NB-IoT and Other LPWAN Technologies

6.1.6. NFC, Wired-to-Cloud and Other Connectivity Technologies
6.1.6.1. Near-Field Communication
6.1.6.2. Ethernet-Connected Medical Devices
6.1.6.3. Proprietary Wireless Connectivity
6.1.6.4. Hybrid Edge-to-Cloud Gateways

What this section provides: This section evaluates the connectivity architectures enabling cloud-connected medical devices and identifies how Wi-Fi, Bluetooth, cellular, 5G, LPWAN, and gateway-based technologies influence deployment economics and clinical reliability.

7. U.S. Cloud-Connected Medical Devices Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)

7.1.2. Chronic Disease Monitoring and Management
7.1.2.1. Diabetes Management
7.1.2.2. Cardiovascular Disease Management
7.1.2.3. Hypertension Monitoring
7.1.2.4. Respiratory Disease Management
7.1.2.5. Sleep Disorder Management
7.1.2.6. Multi-Chronic Condition Monitoring

7.1.3. Acute and Continuous Patient Monitoring
7.1.3.1. Intensive Care Unit Monitoring
7.1.3.2. General Ward Monitoring
7.1.3.3. Emergency Department Monitoring
7.1.3.4. Perioperative Monitoring
7.1.3.5. Neonatal and Pediatric Monitoring
7.1.3.6. Centralized and Virtual Patient Surveillance

7.1.4. Connected Therapy and Medication Delivery
7.1.4.1. Infusion Therapy
7.1.4.2. Insulin Delivery
7.1.4.3. Respiratory Therapy
7.1.4.4. Sleep Therapy
7.1.4.5. Renal and Dialysis Therapy
7.1.4.6. Medication Adherence and Connected Therapeutics

7.1.5. Diagnostic and Clinical Decision Support
7.1.5.1. Cardiac Diagnostics
7.1.5.2. Connected Imaging
7.1.5.3. Point-of-Care Diagnostics
7.1.5.4. Remote Clinical Examination
7.1.5.5. Neurological Diagnostics
7.1.5.6. AI-Assisted Device Data Interpretation

7.1.6. Post-Acute, Home and Rehabilitation Monitoring
7.1.6.1. Hospital-at-Home
7.1.6.2. Post-Discharge Monitoring
7.1.6.3. Post-Surgical Surveillance
7.1.6.4. Rehabilitation Monitoring
7.1.6.5. Skilled Nursing and Transitional Care
7.1.6.6. Home Recovery Monitoring

What this section provides: This section helps clients understand demand by clinical use case and identifies where cloud-connected devices are creating the greatest clinical, reimbursement, workflow, and care-delivery value.

8. U.S. Cloud-Connected Medical Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)

8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Community Hospitals
8.1.2.3. Multi-Hospital Integrated Delivery Networks
8.1.2.4. Specialty Hospitals
8.1.2.5. Critical Access and Rural Hospitals

8.1.3. Ambulatory Centers and Physician Practices
8.1.3.1. Primary Care Practices
8.1.3.2. Cardiology Practices
8.1.3.3. Endocrinology and Diabetes Clinics
8.1.3.4. Ambulatory Surgery Centers
8.1.3.5. Multispecialty Physician Groups

8.1.4. Home Healthcare and Remote Monitoring Providers
8.1.4.1. Remote Patient Monitoring Companies
8.1.4.2. Home Health Agencies
8.1.4.3. Hospital-at-Home Providers
8.1.4.4. Virtual Care Organizations
8.1.4.5. Chronic Care Management Providers

8.1.5. Long-Term Care and Post-Acute Facilities
8.1.5.1. Skilled Nursing Facilities
8.1.5.2. Rehabilitation Facilities
8.1.5.3. Assisted Living Facilities
8.1.5.4. Long-Term Acute Care Hospitals

8.1.6. Diagnostic and Specialty Care Providers
8.1.6.1. Diagnostic Imaging Centers
8.1.6.2. Cardiac Monitoring Providers
8.1.6.3. Sleep Centers
8.1.6.4. Specialty Diagnostic Networks
8.1.6.5. Clinical Research and Monitoring Organizations

What this section provides: This section identifies which U.S. care settings and customer groups are expected to drive connected-device purchasing, recurring monitoring demand, cloud-platform utilization, and enterprise standardization.

9. U.S. Cloud-Connected Medical Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)

9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Department-Level Procurement
9.1.2.2. Enterprise Medical Device Standardization
9.1.2.3. Capital Equipment Procurement
9.1.2.4. Software and Cloud Subscription Procurement

9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Hospital Device Contracts
9.1.3.2. Enterprise Connectivity Agreements
9.1.3.3. Device-as-a-Service Contracts
9.1.3.4. Multi-Year Software and Service Agreements

9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional Purchasing Collaboratives
9.1.4.3. Aggregated Health System Procurement

9.1.5. Distributor, Specialty Supplier and Channel Partner Sales
9.1.5.1. Medical Device Distributors
9.1.5.2. Connectivity and Integration Partners
9.1.5.3. Home Monitoring Device Fulfillment Partners
9.1.5.4. Specialty Medical Technology Resellers

9.1.6. Ambulatory, Home and Digital Care Procurement
9.1.6.1. Physician Practice Procurement
9.1.6.2. Remote Monitoring Program Procurement
9.1.6.3. Home Healthcare Procurement
9.1.6.4. Patient Fulfillment and Direct Shipment Models

What this section provides: This section explains how cloud-connected medical devices are purchased in the U.S., including health-system contracting, IDN standardization, GPO influence, cloud subscriptions, remote-monitoring procurement, and recurring service agreements.

10. U.S. Cloud-Connected Medical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital and Connected-Care Infrastructure Analysis
10.1.4. Regional Remote Patient Monitoring Adoption Analysis
10.1.5. Regional Digital Health and Cloud Readiness Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Medical Device Cybersecurity Readiness
10.1.8. Regional Market Attractiveness Index

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Connected-Care Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Connected-Care Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Connected-Care Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Connected-Care Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level market intelligence across all 50 U.S. states, helping clients identify connected-device adoption hotspots, health-system procurement hubs, digital-health readiness, remote-monitoring opportunities, and state-level commercial priorities.

11. U.S. Cloud-Connected Medical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Device Portfolio Breadth
11.2.2. Cloud Platform Capability
11.2.3. Interoperability Capability
11.2.4. Cybersecurity Capability
11.2.5. Installed Base and Enterprise Penetration
11.2.6. Recurring Revenue and Service Model
11.2.7. U.S. Regulatory Positioning

11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players

11.4. Company Profiles

11.4.1. Abbott Laboratories
11.4.2. Medtronic
11.4.3. Dexcom, Inc.
11.4.4. GE HealthCare Technologies Inc.
11.4.5. Koninklijke Philips N.V.
11.4.6. Baxter International Inc.
11.4.7. Becton, Dickinson and Company
11.4.8. Masimo Corporation
11.4.9. ResMed Inc.
11.4.10. Boston Scientific Corporation
11.4.11. iRhythm Technologies, Inc.
11.4.12. Insulet Corporation
11.4.13. Tandem Diabetes Care, Inc.
11.4.14. Edwards Lifesciences Corporation
11.4.15. BIOTRONIK
11.4.16. ZOLL Medical Corporation
11.4.17. OMRON Healthcare, Inc.
11.4.18. Nihon Kohden Corporation
11.4.19. Drägerwerk AG & Co. KGaA
11.4.20. ICU Medical, Inc.
11.4.21. Fresenius Kabi
11.4.22. AliveCor, Inc.
11.4.23. BioIntelliSense, Inc.
11.4.24. VitalConnect, Inc.
11.4.25. Empatica Inc.

11.5. Company Profile Framework
11.5.1. Company Overview
11.5.2. Cloud-Connected Medical Device Portfolio
11.5.3. U.S. Market Strategy
11.5.4. Connected Platform and Software Capabilities
11.5.5. Interoperability and EHR Integration
11.5.6. Cybersecurity Strategy
11.5.7. Financial and Commercial Positioning
11.5.8. Regulatory Pipeline and FDA Updates
11.5.9. Partnerships and Strategic Collaborations
11.5.10. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, connected-device portfolio positioning, platform capabilities, cybersecurity readiness, recurring-revenue exposure, innovation direction, and strategic intelligence on leading U.S. market participants.

12. U.S. Cloud-Connected Medical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact

12.2.1. AI-Enabled Device Intelligence
12.2.2. Edge AI and Edge-Cloud Medical Computing
12.2.3. 5G-Connected Medical Devices
12.2.4. Clinical-Grade Wearable Biosensors
12.2.5. Next-Generation Continuous Monitoring
12.2.6. Cloud-Based Medical Device Fleet Management
12.2.7. Digital Twins and Predictive Device Maintenance
12.2.8. Autonomous and Closed-Loop Therapeutic Systems
12.2.9. Smart Hospital and Virtual Nursing Infrastructure
12.2.10. Hospital-at-Home Technology Ecosystems

12.3. Evolution of Device-as-a-Service Business Models
12.4. Evolution of Cloud Subscription and Recurring Revenue Models
12.5. Future Medical Device Cybersecurity Requirements
12.6. Emerging Interoperability Standards
12.7. Role of Hyperscale Cloud Providers in Medtech
12.8. Emerging Business Trends
12.9. Business Opportunities for Startups and Existing Players
12.10. Investment Prioritization Matrix
12.11. High-Growth Segment Opportunity Matrix
12.12. Regional Opportunity Matrix, 2026–2035

What this section provides: This section prepares clients for future technology shifts, evolving connected-device architectures, regulatory changes, recurring-revenue models, market structure changes, investment opportunities, and adoption scenarios through 2035.

13. U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations

13.1. Recommendations for Medical Device Manufacturers
13.1.1. Connected Product Portfolio Strategy
13.1.2. Cloud Platform Strategy
13.1.3. Cybersecurity-by-Design Strategy
13.1.4. Interoperability and EHR Integration Strategy
13.1.5. Recurring Revenue Development Strategy

13.2. Recommendations for Hospitals and Integrated Health Systems
13.2.1. Device Standardization Strategy
13.2.2. Enterprise Connectivity Architecture
13.2.3. Cybersecurity and Vendor Risk Management
13.2.4. Remote Monitoring Program Development
13.2.5. Connected Device Total Cost of Ownership Assessment

13.3. Recommendations for Investors and Private Equity Firms
13.3.1. High-Growth Device Category Prioritization
13.3.2. Platform Versus Hardware Investment Assessment
13.3.3. Recurring Revenue Quality Assessment
13.3.4. Regulatory and Cybersecurity Due Diligence

13.4. Recommendations for Cloud, Connectivity and Technology Partners
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for Remote Patient Monitoring Providers
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Hospital Enterprise Sales Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Partnership and M&A Opportunity Assessment
13.12. State-Level Market Entry Prioritization

What this section provides: This section converts market intelligence into actionable recommendations for product development, cybersecurity, hospital selling, market entry, portfolio expansion, partnerships, investment decisions, and competitive differentiation.

14. U.S. Cloud-Connected Medical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimation Limitation
14.6. Regulatory and Reimbursement Information Limitation
14.7. Competitive Intelligence Limitation
14.8. Legal Disclaimer
14.9. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s market boundaries, analytical limitations, legal boundaries, state-level estimation methodology, third-party data-use terms, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Cloud-Connected Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. Cloud-Connected Medical Devices Market: Research Methodology Framework
TABLE 4: U.S. Cloud-Connected Medical Devices Market: Key Assumptions
TABLE 5: U.S. Cloud-Connected Medical Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Cloud-Connected Medical Devices Market: Stakeholder Analysis
TABLE 7: U.S. Cloud-Connected Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Cloud-Connected Medical Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Cloud-Connected Medical Devices Market: Market Attractiveness Index
TABLE 10: U.S. Cloud-Connected Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Cloud-Connected Medical Devices Market: Base Year Market Positioning, 2025 (US$ Billion)
TABLE 12: U.S. Cloud-Connected Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Cloud-Connected Medical Devices Market: High-Growth Opportunity Areas, 2026–2035
TABLE 14: U.S. Cloud-Connected Medical Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Cloud-Connected Medical Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Cloud-Connected Medical Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Cloud-Connected Medical Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Cloud-Connected Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Cloud-Connected Medical Devices Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Cloud-Connected Medical Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 21: U.S. Cloud-Connected Medical Devices Market: Total Cost of Ownership Analysis
TABLE 22: U.S. Cloud-Connected Medical Devices Market: Remote Monitoring Economics and Reimbursement Impact
TABLE 23: U.S. Cloud-Connected Medical Devices Market: Enterprise Device Standardization Trends
TABLE 24: U.S. Cloud-Connected Medical Devices Market: PESTEL Analysis
TABLE 25: U.S. Cloud-Connected Medical Devices Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Cloud-Connected Medical Devices Market: Pricing Trend Analysis, 2025–2035
TABLE 27: U.S. Cloud-Connected Medical Devices Market: Value Chain Analysis
TABLE 28: U.S. Cloud-Connected Medical Devices Market: Supply Chain Analysis
TABLE 29: U.S. Cloud-Connected Medical Devices Market: Digitalization and IoMT Impact
TABLE 30: U.S. Cloud-Connected Medical Devices Market: Medical Device Interoperability Landscape
TABLE 31: U.S. Cloud-Connected Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Cloud-Connected Medical Devices Market: Medical Device Cybersecurity Framework
TABLE 33: U.S. Cloud-Connected Medical Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 34: U.S. Cloud-Connected Medical Devices Market: HIPAA, Privacy and PHI Considerations
TABLE 35: U.S. Cloud-Connected Medical Devices Market: EHR, API and FHIR Interoperability Trends
TABLE 36: U.S. Cloud-Connected Medical Devices Market: Cloud Infrastructure and Data Residency Considerations
TABLE 37: U.S. Cloud-Connected Medical Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 38: U.S. Cloud-Connected Medical Devices Market: Semiconductor and Connectivity Component Supply Risk
TABLE 39: U.S. Cloud-Connected Medical Devices Market: Hospital Value Analysis Committee and CISO Decision Framework
TABLE 40: U.S. Cloud-Connected Medical Devices Market: Device Category Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Device Category
TABLE 42: U.S. Cloud-Connected Medical Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 43: U.S. Cloud-Connected Medical Devices Market: Segment Share Analysis, by Device Category, 2025 & 2035 (%)
TABLE 44: U.S. Cloud-Connected Medical Devices Market: Connected Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Cloud-Connected Medical Devices Market: Diabetes and Metabolic Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Cloud-Connected Medical Devices Market: Connected Cardiovascular and Implantable Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Cloud-Connected Medical Devices Market: Connected Therapeutic and Infusion Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Cloud-Connected Medical Devices Market: Connected Diagnostic, Imaging and Other Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Cloud-Connected Medical Devices Market: Connectivity Technology Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Connectivity Technology
TABLE 51: U.S. Cloud-Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 52: U.S. Cloud-Connected Medical Devices Market: Segment Share Analysis, by Connectivity Technology, 2025 & 2035 (%)
TABLE 53: U.S. Cloud-Connected Medical Devices Market: Wi-Fi and Enterprise Wireless Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Cloud-Connected Medical Devices Market: Bluetooth and Bluetooth Low Energy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Cloud-Connected Medical Devices Market: Cellular Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Cloud-Connected Medical Devices Market: 5G and Low-Power Wide-Area Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Cloud-Connected Medical Devices Market: NFC, Wired-to-Cloud and Other Connectivity Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Cloud-Connected Medical Devices Market: Application Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by Application
TABLE 60: U.S. Cloud-Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 61: U.S. Cloud-Connected Medical Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 62: U.S. Cloud-Connected Medical Devices Market: Chronic Disease Monitoring and Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Cloud-Connected Medical Devices Market: Acute and Continuous Patient Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Cloud-Connected Medical Devices Market: Connected Therapy and Medication Delivery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Cloud-Connected Medical Devices Market: Diagnostic and Clinical Decision Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Cloud-Connected Medical Devices Market: Post-Acute, Home and Rehabilitation Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Cloud-Connected Medical Devices Market: End User Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by End User
TABLE 69: U.S. Cloud-Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 70: U.S. Cloud-Connected Medical Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 71: U.S. Cloud-Connected Medical Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Cloud-Connected Medical Devices Market: Ambulatory Centers and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Cloud-Connected Medical Devices Market: Home Healthcare and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Cloud-Connected Medical Devices Market: Long-Term Care and Post-Acute Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Cloud-Connected Medical Devices Market: Diagnostic and Specialty Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Cloud-Connected Medical Devices Market: Procurement Channel Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 78: U.S. Cloud-Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 79: U.S. Cloud-Connected Medical Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 80: U.S. Cloud-Connected Medical Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Cloud-Connected Medical Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Cloud-Connected Medical Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Cloud-Connected Medical Devices Market: Distributor, Specialty Supplier and Channel Partner Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Cloud-Connected Medical Devices Market: Ambulatory, Home and Digital Care Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Cloud-Connected Medical Devices Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Geography
TABLE 87: U.S. Cloud-Connected Medical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Cloud-Connected Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: West Region U.S. Cloud-Connected Medical Devices Market: Regional Overview and Trends
TABLE 90: West Region U.S. Cloud-Connected Medical Devices Market: Key Manufacturers and Connected-Care Procurement Ecosystem
TABLE 91: West Region U.S. Cloud-Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Cloud-Connected Medical Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Cloud-Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Cloud-Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Cloud-Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Cloud-Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 97: California Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Washington Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Arizona Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Colorado Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Oregon Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Utah Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Nevada Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: New Mexico Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Idaho Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Montana Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Wyoming Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Alaska Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Hawaii Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Northeast Region U.S. Cloud-Connected Medical Devices Market: Regional Overview and Trends
TABLE 111: Northeast Region U.S. Cloud-Connected Medical Devices Market: Key Manufacturers and Connected-Care Procurement Ecosystem
TABLE 112: Northeast Region U.S. Cloud-Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Cloud-Connected Medical Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Cloud-Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Cloud-Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Cloud-Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Cloud-Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 118: New York Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Massachusetts Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: New Jersey Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Pennsylvania Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Connecticut Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Maine Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Vermont Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: New Hampshire Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Rhode Island Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Delaware Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Cloud-Connected Medical Devices Market: Regional Overview and Trends
TABLE 129: South Region U.S. Cloud-Connected Medical Devices Market: Key Manufacturers and Connected-Care Procurement Ecosystem
TABLE 130: South Region U.S. Cloud-Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 131: South Region U.S. Cloud-Connected Medical Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Cloud-Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Cloud-Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Cloud-Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Cloud-Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 136: Texas Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Florida Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Georgia Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: North Carolina Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Tennessee Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: South Carolina Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Alabama Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Mississippi Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Louisiana Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Arkansas Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Kentucky Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Oklahoma Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Virginia Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Maryland Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: West Virginia Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Cloud-Connected Medical Devices Market: Regional Overview and Trends
TABLE 152: Midwest Region U.S. Cloud-Connected Medical Devices Market: Key Manufacturers and Connected-Care Procurement Ecosystem
TABLE 153: Midwest Region U.S. Cloud-Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 154: Midwest Region U.S. Cloud-Connected Medical Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Cloud-Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Cloud-Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Cloud-Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Cloud-Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 159: Illinois Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Ohio Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Michigan Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Minnesota Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Indiana Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Wisconsin Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Missouri Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Iowa Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Kansas Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Nebraska Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: North Dakota Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: South Dakota Cloud-Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: U.S. Cloud-Connected Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 172: U.S. Cloud-Connected Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 173: U.S. Cloud-Connected Medical Devices Market: Company Positioning Matrix
TABLE 174: U.S. Cloud-Connected Medical Devices Market: Connected Device Portfolio Benchmarking
TABLE 175: U.S. Cloud-Connected Medical Devices Market: Cloud Platform, Interoperability and Cybersecurity Benchmarking
TABLE 176: U.S. Cloud-Connected Medical Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 177: Abbott Laboratories: Company Profile
TABLE 178: Medtronic: Company Profile
TABLE 179: Dexcom, Inc.: Company Profile
TABLE 180: GE HealthCare Technologies Inc.: Company Profile
TABLE 181: Koninklijke Philips N.V.: Company Profile
TABLE 182: Baxter International Inc.: Company Profile
TABLE 183: Becton, Dickinson and Company: Company Profile
TABLE 184: Masimo Corporation: Company Profile
TABLE 185: ResMed Inc.: Company Profile
TABLE 186: Boston Scientific Corporation: Company Profile
TABLE 187: iRhythm Technologies, Inc.: Company Profile
TABLE 188: Insulet Corporation: Company Profile
TABLE 189: Tandem Diabetes Care, Inc.: Company Profile
TABLE 190: Edwards Lifesciences Corporation: Company Profile
TABLE 191: BIOTRONIK: Company Profile
TABLE 192: ZOLL Medical Corporation: Company Profile
TABLE 193: OMRON Healthcare, Inc.: Company Profile
TABLE 194: Nihon Kohden Corporation: Company Profile
TABLE 195: Drägerwerk AG & Co. KGaA: Company Profile
TABLE 196: ICU Medical, Inc.: Company Profile
TABLE 197: Fresenius Kabi: Company Profile
TABLE 198: AliveCor, Inc.: Company Profile
TABLE 199: BioIntelliSense, Inc.: Company Profile
TABLE 200: VitalConnect, Inc.: Company Profile
TABLE 201: Empatica Inc.: Company Profile
TABLE 202: U.S. Cloud-Connected Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 203: U.S. Cloud-Connected Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 204: U.S. Cloud-Connected Medical Devices Market: AI, Edge AI and Cloud Intelligence Opportunity Matrix
TABLE 205: U.S. Cloud-Connected Medical Devices Market: 5G and Next-Generation Connectivity Opportunity Matrix
TABLE 206: U.S. Cloud-Connected Medical Devices Market: Device-as-a-Service and Cloud Subscription Model Outlook
TABLE 207: U.S. Cloud-Connected Medical Devices Market: Emerging Business Trends
TABLE 208: U.S. Cloud-Connected Medical Devices Market: Business Opportunities for Startups and Existing Players
TABLE 209: U.S. Cloud-Connected Medical Devices Market: Investment Prioritization Matrix
TABLE 210: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for Medical Device Manufacturers
TABLE 211: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 212: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 213: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for Cloud and Connectivity Partners
TABLE 214: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 215: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for Remote Patient Monitoring Providers
TABLE 216: U.S. Cloud-Connected Medical Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 217: U.S. Cloud-Connected Medical Devices Market: Go-to-Market and State-Level Market Entry Strategy
TABLE 218: U.S. Cloud-Connected Medical Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 219: U.S. Cloud-Connected Medical Devices Market: Scope Limitation
TABLE 220: U.S. Cloud-Connected Medical Devices Market: Data Use Limitation
TABLE 221: U.S. Cloud-Connected Medical Devices Market: Forecasting and State-Level Estimation Limitation
TABLE 222: U.S. Cloud-Connected Medical Devices Market: Regulatory and Competitive Intelligence Limitation
TABLE 223: U.S. Cloud-Connected Medical Devices Market: Legal and Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Cloud-Connected Medical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Cloud-Connected Medical Devices Market Ecosystem
FIGURE 4: Stakeholder and Connected-Care Value Network
FIGURE 5: Executive Market Snapshot, 2025
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: U.S. Cloud-Connected Medical Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 8: U.S. Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 9: U.S. Cloud-Connected Medical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 10: U.S. Cloud-Connected Medical Devices Market Dynamics
FIGURE 11: Drivers, Restraints, Opportunities and Challenges Impact Matrix
FIGURE 12: Innovation & Patent Landscape, 2021–2025
FIGURE 13: Clinical Workflow Economics Framework
FIGURE 14: Hospital Capital Procurement Decision Framework
FIGURE 15: Connected Medical Device Total Cost of Ownership Framework
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: Digitalization and IoMT Impact Framework
FIGURE 21: Medical Device Interoperability Architecture
FIGURE 22: FDA Regulatory and Cybersecurity Framework
FIGURE 23: CMS Remote Monitoring and Reimbursement Landscape
FIGURE 24: Device Category Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Device Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Connected Patient Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Diabetes and Metabolic Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Connected Cardiovascular and Implantable Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Connected Therapeutic and Infusion Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Connected Diagnostic, Imaging and Other Medical Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Connectivity Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 32: Connectivity Technology Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Wi-Fi and Enterprise Wireless Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Bluetooth and Bluetooth Low Energy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Cellular Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: 5G and Low-Power Wide-Area Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: NFC, Wired-to-Cloud and Other Connectivity Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Chronic Disease Monitoring and Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Acute and Continuous Patient Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Connected Therapy and Medication Delivery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Diagnostic and Clinical Decision Support Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Post-Acute, Home and Rehabilitation Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 46: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Ambulatory Centers and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Home Healthcare and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Long-Term Care and Post-Acute Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Diagnostic and Specialty Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 53: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Distributor, Specialty Supplier and Channel Partner Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Ambulatory, Home and Digital Care Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 60: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: West Region U.S. Cloud-Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 62: West Region Market Share Analysis by State, 2025
FIGURE 63: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: California Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Washington Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Arizona Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Colorado Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Oregon Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Utah Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Nevada Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New Mexico Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Idaho Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Montana Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Wyoming Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Alaska Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Hawaii Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Northeast Region U.S. Cloud-Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 78: Northeast Region Market Share Analysis by State, 2025
FIGURE 79: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New York Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Massachusetts Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Jersey Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Pennsylvania Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Connecticut Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Maine Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Vermont Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: New Hampshire Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Rhode Island Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Delaware Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: South Region U.S. Cloud-Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 91: South Region Market Share Analysis by State, 2025
FIGURE 92: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Texas Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Florida Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Georgia Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: North Carolina Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Tennessee Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: South Carolina Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Alabama Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Mississippi Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Louisiana Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Arkansas Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Kentucky Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Oklahoma Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Virginia Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Maryland Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: West Virginia Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Midwest Region U.S. Cloud-Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 109: Midwest Region Market Share Analysis by State, 2025
FIGURE 110: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Illinois Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Ohio Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Michigan Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Minnesota Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Indiana Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Wisconsin Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Missouri Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Iowa Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Kansas Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Nebraska Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: North Dakota Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: South Dakota Cloud-Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 124: Company Positioning Matrix
FIGURE 125: Connected Medical Device Portfolio Benchmarking
FIGURE 126: Cloud Platform and Interoperability Capability Benchmarking
FIGURE 127: Cybersecurity Capability Benchmarking
FIGURE 128: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 129: Cloud-Connected Medical Device Innovation Roadmap
FIGURE 130: AI and Edge Intelligence Adoption Roadmap
FIGURE 131: 5G and Next-Generation Connectivity Opportunity Map
FIGURE 132: Hospital-at-Home and Remote Monitoring Growth Roadmap
FIGURE 133: Future Market Scenario Analysis, 2026–2035
FIGURE 134: Disruptive Technologies Impact Matrix
FIGURE 135: Emerging Business Trends Matrix
FIGURE 136: Investment Prioritization Matrix
FIGURE 137: Strategic Growth Roadmap for U.S. Cloud-Connected Medical Device Companies
FIGURE 138: Go-to-Market Strategy Framework
FIGURE 139: Product Positioning and Portfolio Expansion Framework
FIGURE 140: Report Scope and Disclaimer Framework